Discover Opportunities months before the RFP drops
Learn more →Retrieving contract details... Hang tight!
See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
Verified decision-maker contacts
Winning vendor information
Budget & renewal data
Clean & enrich your CRM automatically
Track contract spending & renewal dates
Analyze historical pricing trends
Identify upcoming opportunities
Get complete source documentation & analysis
U.S. Army Medical Research Acquisition Activity (USAMRAA)
This contract includes 1 purchase order from Jun 30, 2025 to Jun 30, 2025
| Buyer | Vendor | Issued Date | Quantity |
|---|---|---|---|
| U.S. Army Medical Research Acquisition Activity (USAMRAA) | Innovital Systems Inc | Jun 30, 2025 | 1 |
Full Purchase Intelligence Available
Get complete pricing, descriptions, and financial details for all 1 purchase orders
Unlock Full Details →See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
No public files available for this contract.
Contract documentation may be available through official government sources or agency portals. Starbridge can help you track down and retrieve these files.
U.S. Army Medical Research Acquisition Activity (USAMRAA)
DHA SBIR SEQUENTIAL MEDICAL RESEARCH AND DEVELOPMENT PHASE II CONTRACT TITLED: AGITUBE (NOW CLR),"FURTHER STUDIES TO REFINE DEVICE USE FOR THE MANAGEMENT OF HEMOTHORAX AND OTHER PLEURAL COLLECTIONS" PLEASE NOTE CLR IS NOT AN ABBREVIATION.
Effective Date
Jan 5, 2024
Expires
Effective: Jan 5, 2024
U.S. Army Medical Research Acquisition Activity (USAMRAA)
Expires:
DHA SBIR SEQUENTIAL MEDICAL RESEARCH AND DEVELOPMENT PHASE II CONTRACT TITLED: AGITUBE (NOW CLR),"FURTHER STUDIES TO REFINE DEVICE USE FOR THE MANAGEMENT OF HEMOTHORAX AND OTHER PLEURAL COLLECTIONS" PLEASE NOTE CLR IS NOT AN ABBREVIATION.
ActiveU.S. Army Medical Research Acquisition Activity (USAMRAA)
AWARD OF INNOVITAL'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "NEXT-GENERATION NASOPHARYNGEAL AIRWAY"
Effective Date
Mar 1, 2023
Expires
Effective: Mar 1, 2023
U.S. Army Medical Research Acquisition Activity (USAMRAA)
Expires:
AWARD OF INNOVITAL'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "NEXT-GENERATION NASOPHARYNGEAL AIRWAY"
ActiveU.S. Army Medical Research Acquisition Activity (USAMRAA)
DHA STTR PH II MEDICAL RESEARCH AND DEVELOPMENT CONTRACT FOR PROJECT TITLED, "COMPACT LITTER ASSIST FOR WARFIGHTERS"
Effective Date
Feb 5, 2025
Expires
Effective: Feb 5, 2025
U.S. Army Medical Research Acquisition Activity (USAMRAA)
Expires:
DHA STTR PH II MEDICAL RESEARCH AND DEVELOPMENT CONTRACT FOR PROJECT TITLED, "COMPACT LITTER ASSIST FOR WARFIGHTERS"
ActiveU.S. Army Medical Research Acquisition Activity (USAMRAA)
ARMY MEDICAL RESEARCH AND DEVELOPMENT CONTRACT FOR SBIR PH III PROPOSAL NO. JW210508 TITLED NETWORK-ENABLED TACTICAL COMBAT CASUALTY CARE (NETC3) SCALE-UP.
Effective Date
Sep 7, 2022
Expires
Effective: Sep 7, 2022
U.S. Army Medical Research Acquisition Activity (USAMRAA)
Expires:
ARMY MEDICAL RESEARCH AND DEVELOPMENT CONTRACT FOR SBIR PH III PROPOSAL NO. JW210508 TITLED NETWORK-ENABLED TACTICAL COMBAT CASUALTY CARE (NETC3) SCALE-UP.
ActiveSee who's winning contracts, track spending trends, and identify your best opportunities before your competition.
Schedule Your Demo →Verified decision-maker contacts
Winning vendor information
Budget & renewal data
Clean & enrich your CRM automatically
Track contract spending & renewal dates
Analyze historical pricing trends
Identify upcoming opportunities
Get complete source documentation & analysis